{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "cognitive flexibility inventory",
      "depression",
      "depressive disorder",
      "escitalopram",
      "solution focused group therapy"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "<b>\u76ee\u7684</b>: \u6291\u90c1\u75c7\u53d1\u75c5\u7387\u8f83\u9ad8\uff0c\u5e38\u4f34\u6709\u4e0d\u540c\u7a0b\u5ea6\u7684\u8ba4\u77e5\u529f\u80fd\u51cf\u9000\uff0c\u6307\u5357\u63a8\u8350\u91c7\u7528\u836f\u7269\u6cbb\u7597\u5408\u5e76\u5fc3\u7406\u6cbb\u7597\u51cf\u7f13\u6291\u90c1\u75c7\u72b6\u3002\u7126\u70b9\u89e3\u51b3\u56e2\u4f53\u6cbb\u7597(solution focused group therapy\uff0cSFGT)\u662f\u4e00\u79cd\u8f83\u65b0\u7684\u56e2\u4f53\u5fc3\u7406\u6cbb\u7597\u6280\u672f\u3002\u672c\u7814\u7a76\u65e8\u5728\u63a2\u8ba8SFGT\u8054\u7528\u827e\u53f8\u897f\u915e\u666e\u5170\u4e0e\u5355\u4e00\u670d\u7528\u827e\u53f8\u897f\u915e\u666e\u5170\u5bf9\u6291\u90c1\u75c7\u60a3\u8005\u6291\u90c1\u75c7\u72b6\u548c\u8ba4\u77e5\u7075\u6d3b\u6027\u7684\u5f71\u54cd\u3002<b>\u65b9\u6cd5</b>: \u7eb3\u516584\u4f8b\u7b26\u5408\u300a\u75be\u75c5\u548c\u6709\u5173\u5065\u5eb7\u95ee\u9898\u7684\u56fd\u9645\u7edf\u8ba1\u5206\u7c7b(\u7b2c10\u7248)\u300b\u6291\u90c1\u75c7\u8bca\u65ad\u6807\u51c6\u7684\u60a3\u8005\uff0c\u6309\u7167\u5165\u7ec4\u5148\u540e\u987a\u5e8f\u5c06\u60a3\u8005\u5206\u4e3a\u8054\u5408\u7ec4(<i>n</i>=42)\u548c\u5bf9\u7167\u7ec4(<i>n</i>=42)\uff0c\u5bf9\u7167\u7ec4\u5355\u4e00\u670d\u7528\u827e\u53f8\u897f\u915e\u666e\u5170\uff0c\u8054\u5408\u7ec4\u5728\u5bf9\u7167\u7ec4\u7684\u57fa\u7840\u4e0a\u8054\u7528SFGT\uff0c\u5bf9\u60a3\u8005\u8fdb\u884c\u4e3a\u671f8\u5468\u7684\u6cbb\u7597\u3002\u4f7f\u752824\u9879\u6c49\u5bc6\u5c14\u987f\u6291\u90c1\u91cf\u8868(24-item Hamilton Depression Scale\uff0cHAMD-24)\u548c\u8ba4\u77e5\u7075\u6d3b\u6027\u95ee\u5377(Cognitive Flexibility Inventory\uff0cCFI)\u5206\u522b\u5728\u57fa\u7ebf\u65f6(T<sub>0</sub>)\u3001\u7b2c4\u5468(T<sub>1</sub>)\u3001\u7b2c8\u5468(T<sub>2</sub>)\u5bf9\u60a3\u8005\u8fdb\u884c\u6d4b\u8bc4\uff0c\u6bd4\u8f83\u4e0e\u5206\u67902\u7ec4\u60a3\u8005\u6291\u90c1\u75c7\u72b6\u548c\u8ba4\u77e5\u7075\u6d3b\u6027\u7684\u5dee\u5f02\u3002<b>\u7ed3\u679c</b>: \u5728T<sub>2</sub>\u65f6\uff0c\u8054\u5408\u7ec4\u8131\u843d8\u4f8b\uff0c\u5bf9\u7167\u7ec4\u8131\u843d10\u4f8b\u30022\u7ec4\u60a3\u8005\u5728T<sub>0</sub>\u65f6HAMD\u3001CFI\u603b\u5206\u548c\u7ef4\u5ea6\u5206\u7684\u5dee\u5f02\u5747\u65e0\u7edf\u8ba1\u5b66\u610f\u4e49(\u5747<i>P></i>0.05)\u3002\u5728T<sub>1</sub>\u3001T<sub>2</sub>\u65f6\uff0c\u8054\u5408\u7ec4\u60a3\u8005\u7684HAMD-24\u603b\u5206\u53ca\u7126\u8651\u8eaf\u4f53\u5316\u3001\u8ba4\u77e5\u969c\u788d\u3001\u8fdf\u7f13\u3001\u7edd\u671b\u611f\u7b49\u7ef4\u5ea6\u5206\u5747\u4f4e\u4e8e\u5bf9\u7167\u7ec4\uff0cCFI\u603b\u5206\u53ca\u7ef4\u5ea6\u5206\u5747\u9ad8\u4e8e\u5bf9\u7167\u7ec4\uff0c\u5dee\u5f02\u5747\u5177\u6709\u7edf\u8ba1\u5b66\u610f\u4e49(\u5747<i>P</i><0.05)\u3002<b>\u7ed3\u8bba</b>: SFGT\u80fd\u591f\u6539\u5584\u6291\u90c1\u75c7\u60a3\u8005\u6291\u90c1\u75c7\u72b6\u4e2d\u7684\u7126\u8651\u8eaf\u4f53\u5316\u75c7\u72b6\u3001\u8ba4\u77e5\u969c\u788d\u3001\u8fdf\u7f13\u75c7\u72b6\u53ca\u7edd\u671b\u611f\u75c7\u72b6\uff0c\u4e14\u80fd\u591f\u63d0\u9ad8\u8ba4\u77e5\u7075\u6d3b\u6027\u3002."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "38044645",
  "DateCompleted": {
    "Year": "2023",
    "Month": "12",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "16"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng",
      "chi"
    ],
    "ELocationID": [
      "10.11817/j.issn.1672-7347.2023.230097",
      "1672-7347(2023)09-1343-07"
    ],
    "Journal": {
      "ISSN": "1672-7347",
      "JournalIssue": {
        "Volume": "48",
        "Issue": "9",
        "PubDate": {
          "MedlineDate": "2023 Sept 28"
        }
      },
      "Title": "Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences",
      "ISOAbbreviation": "Zhong Nan Da Xue Xue Bao Yi Xue Ban"
    },
    "ArticleTitle": "Effect of solution focused group therapy on depressive symptoms and cognitive flexibility of depressive disorder patient.",
    "Pagination": {
      "StartPage": "1343",
      "EndPage": "1349",
      "MedlinePgn": "1343-1349"
    },
    "Abstract": {
      "AbstractText": [
        "Depression is often accompanied by various degrees of cognitive decline, with a high incidence. Guidelines recommend medication combined with psychological therapy. Solution focused group therapy (SFGT) is a newer group psychotherapy technique. This study aims to explore the difference between SFGT combined with escitalopram and only use escitalopram in treating depression.",
        "A total of 84 patients who met the diagnostic criteria of international classification of diseases-10 (ICD-10) were enrolled into the combined group (SFGT combined with escitalopram, <i>n</i>=42) and the control group (only escitalopram, <i>n</i>=42) for an 8-week treatment. Patients were measured with the 24-item Hamilton Depression Scale (HAMD-24) and the Cognitive Flexibility Inventory (CFI) at baseline (T<sub>0</sub>), week 4 (T<sub>1</sub>), and week 8 (T<sub>2</sub>), respectively. Differences in depressive symptoms and cognitive flexibility between the 2 groups were compared and analyzed.",
        "At T<sub>2</sub>, 8 patients were dislodged in the combined group and 10 in the control group. There was no difference in the subscales and total scores of HAMD-24 and CFI between the 2 groups at T<sub>0</sub> (all <i>P></i>0.05). At T<sub>1</sub> and T<sub>2</sub>, compared with the control group, the total scores and anxiety somatization, cognitive impairment, delay, and a sense of despair subscales scores of HAMD-24 were lower, and the total scores and subscales scores of CFI in the combined group were higher (all <i>P</i><0.05).",
        "SFGT combined with escitalopram is more effective than monotherapy for improving the anxiety somatization symptoms, cognitive impairment, retardation symptoms and despair symptoms, and increasing the cognitive flexibility."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Female Psychiatry, Yunnan Psychiatric Hospital, Kunming 650224. 416304916@qq.com."
          }
        ],
        "LastName": "Duan",
        "ForeName": "Deng'ai",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Disorder Recovery Zone 2, Yunnan Psychiatric Hospital, Kunming 650224."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Wei",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Mental Disorder Recovery Zone 2, Yunnan Psychiatric Hospital, Kunming 650224."
          }
        ],
        "LastName": "Zhang",
        "ForeName": "Jing",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Cardiovascular Medicine, Yunnan Third People's Hospital, Kunming 650011, China. 576888739@qq.com."
          }
        ],
        "LastName": "Gu",
        "ForeName": "Zhanglin",
        "Initials": "Z"
      }
    ],
    "GrantList": [
      {
        "GrantID": "2020-21-01-001",
        "Agency": "the Health Scientific Research Project of Kunming Municipal Health Commission",
        "Country": ""
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ],
    "VernacularTitle": "\u7126\u70b9\u89e3\u51b3\u56e2\u4f53\u6cbb\u7597\u5bf9\u6291\u90c1\u75c7\u60a3\u8005\u6291\u90c1\u75c7\u72b6\u548c\u8ba4\u77e5\u7075\u6d3b\u6027\u7684\u5f71\u54cd."
  },
  "MedlineJournalInfo": {
    "Country": "China",
    "MedlineTA": "Zhong Nan Da Xue Xue Bao Yi Xue Ban",
    "NlmUniqueID": "101230586",
    "ISSNLinking": "1672-7347"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0DHU5B8D6V",
      "NameOfSubstance": "Citalopram"
    },
    {
      "RegistryNumber": "4O4S742ANY",
      "NameOfSubstance": "Escitalopram"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use",
        "adverse effects"
      ],
      "DescriptorName": "Citalopram"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Escitalopram"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapy, Group"
    },
    {
      "QualifierName": [
        "complications",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cognition"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ]
}